ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 19:20
ACADIA Pharmaceuticals Market Cap : 5.100B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.078B |
| August 20, 2026 | 4.999B |
| August 19, 2026 | 5.200B |
| August 18, 2026 | 5.195B |
| August 17, 2026 | 4.994B |
| August 14, 2026 | 4.861B |
| August 13, 2026 | 4.885B |
| August 12, 2026 | 5.069B |
| August 11, 2026 | 5.062B |
| August 10, 2026 | 5.059B |
| August 07, 2026 | 5.028B |
| August 06, 2026 | 4.897B |
| August 05, 2026 | 4.957B |
| August 04, 2026 | 4.673B |
| August 03, 2026 | 4.408B |
| July 31, 2026 | 4.426B |
| July 30, 2026 | 4.542B |
| July 29, 2026 | 4.506B |
| July 28, 2026 | 4.450B |
| July 27, 2026 | 4.344B |
| July 24, 2026 | 4.250B |
| July 23, 2026 | 4.248B |
| July 22, 2026 | 4.270B |
| July 21, 2026 | 4.351B |
| July 20, 2026 | 4.293B |
| Date | Value |
|---|---|
| July 17, 2026 | 4.380B |
| July 16, 2026 | 4.385B |
| July 15, 2026 | 4.435B |
| July 14, 2026 | 4.361B |
| July 13, 2026 | 4.363B |
| July 10, 2026 | 4.486B |
| July 09, 2026 | 4.518B |
| July 08, 2026 | 4.448B |
| July 07, 2026 | 4.482B |
| July 06, 2026 | 4.409B |
| July 02, 2026 | 4.443B |
| July 01, 2026 | 4.311B |
| June 30, 2026 | 4.328B |
| June 29, 2026 | 4.311B |
| June 26, 2026 | 4.332B |
| June 25, 2026 | 4.058B |
| June 24, 2026 | 3.997B |
| June 23, 2026 | 3.867B |
| June 22, 2026 | 3.779B |
| June 18, 2026 | 3.699B |
| June 17, 2026 | 3.695B |
| June 16, 2026 | 3.583B |
| June 15, 2026 | 3.638B |
| June 12, 2026 | 3.608B |
| June 11, 2026 | 3.660B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 25.72B |
| Agios Pharmaceuticals, Inc. | 1.943B |
| Biogen, Inc. | 32.21B |
| Insmed, Inc. | 27.07B |
| Vertex Pharmaceuticals, Inc. | 138.77B |
Market Cap Related Metrics
| PE Ratio | 13.34 |
| PS Ratio | 4.473 |
| PEG Ratio | 0.1997 |
| Price to Book Value | 3.903 |
| Price to Free Cash Flow | 34.97 |
| Price | 29.63 |
| Earnings Yield | 7.49% |
| PEGY Ratio | 0.1997 |
| Operating PE Ratio | 58.97 |
| Normalized PE Ratio | 13.34 |